Terms: = Endocrine gland cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
108 results:
1. Nuclear MAST4 Suppresses foxo3 through Interaction with AKT3 and Induces Chemoresistance in Pancreatic Ductal Carcinoma.
Fujiwara-Tani R; Sasaki T; Bhawal UK; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Fujii K; Ohmori H; Sho M; Kuniyasu H
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612866
[TBL] [Abstract] [Full Text] [Related]
2. The roles of autophagy, ferroptosis and pyroptosis in the anti-ovarian cancer mechanism of harmine and their crosstalk.
Zhu J; Zhu H; Zhu Q; Xu SL; Xiao L; Zhang MY; Gao J
Sci Rep; 2024 Mar; 14(1):6504. PubMed ID: 38499622
[TBL] [Abstract] [Full Text] [Related]
3. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
Mikhael S; Kurdi A; Khoueiry-Zgheib N; Tahtouh R; Nasr R; Hilal G
PLoS One; 2024; 19(3):e0298127. PubMed ID: 38489280
[TBL] [Abstract] [Full Text] [Related]
4. Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.
Uddin MH; Al-Hallak MN; Khan HY; Aboukameel A; Li Y; Bannoura SF; Dyson G; Kim S; Mzannar Y; Azar I; Odisho T; Mohamed A; Landesman Y; Kim S; Beydoun R; Mohammad RM; Philip PA; Shields AF; Azmi AS
Clin Transl Med; 2023 Dec; 13(12):e1513. PubMed ID: 38131168
[TBL] [Abstract] [Full Text] [Related]
5. Prolyl isomerase Pin1 promotes autophagy and cancer cell viability through activating foxo3 signalling.
Long J; Wang J; Dong Y; Yang J; Xie G; Tong Y
Cell Signal; 2024 Jan; 113():110940. PubMed ID: 38084839
[TBL] [Abstract] [Full Text] [Related]
6. Epigallocatechin gallate inhibits ovarian cancer cell growth and induces cell apoptosis via activation of foxo3A.
Zhang Z; Zhang Q; Yu Y; Su S
In Vitro Cell Dev Biol Anim; 2023 Dec; 59(10):739-746. PubMed ID: 38038884
[TBL] [Abstract] [Full Text] [Related]
7. PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth.
Chen S; Chen J; Du W; Mickelsen DM; Shi H; Yu H; Kumar S; Yan C
Circ Res; 2023 Jul; 133(2):138-157. PubMed ID: 37232184
[TBL] [Abstract] [Full Text] [Related]
8. Screening and Identification of a Prognostic Model of Ovarian cancer by Combination of Transcriptomic and Proteomic Data.
Jiang J; Chen Z; Wang H; Wang Y; Zheng J; Guo Y; Jiang Y; Mo Z
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189432
[TBL] [Abstract] [Full Text] [Related]
9. Correlation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma.
Zhao F; Zhu S; Fang J; Dong H; Zhu C
Head Neck; 2023 Jul; 45(7):1654-1662. PubMed ID: 37097909
[TBL] [Abstract] [Full Text] [Related]
10. Butein Inhibits Cell Growth by Blocking the IL-6/IL-6Rα Interaction in Human Ovarian cancer and by Regulation of the IL-6/STAT3/foxo3a Pathway.
Park SA; Seo YJ; Kim LK; Kim HJ; Yoon KD; Heo TH
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047012
[No Abstract] [Full Text] [Related]
11. Identification of potential LncRNAs as papillary thyroid carcinoma biomarkers based on integrated bioinformatics analysis using TCGA and RNA sequencing data.
Feng JL; Zheng WJ; Xu L; Zhou QY; Chen J
Sci Rep; 2023 Mar; 13(1):4350. PubMed ID: 36928327
[TBL] [Abstract] [Full Text] [Related]
12. Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications.
Li Y; He Y; Chen Y; He Z; Yang F; Xing C
Apoptosis; 2023 Apr; 28(3-4):576-593. PubMed ID: 36695983
[TBL] [Abstract] [Full Text] [Related]
13. Pancancer analysis of SKA1 mutation and its association with the diagnosis and prognosis of human cancers.
Lan H; Yuan J; Zhang R; Jiang B; Li Q; Huang Z; Chen P; Xiang H; Zeng X; Xiao S
Genomics; 2023 Mar; 115(2):110554. PubMed ID: 36587749
[TBL] [Abstract] [Full Text] [Related]
14. An
Lee CM; Kang MA; Bae JS; Park K; Yang YH; Lee J; Jang KY; Park SH
Hum Exp Toxicol; 2022; 41():9603271221089257. PubMed ID: 35417658
[TBL] [Abstract] [Full Text] [Related]
15. RBM47/SNHG5/foxo3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma.
Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Lv C; Zhang H
Cell Death Dis; 2022 Mar; 13(3):270. PubMed ID: 35338124
[TBL] [Abstract] [Full Text] [Related]
16.
Shen L; Lee S; Joo JC; Hong E; Cui ZY; Jo E; Park SJ; Jang HJ
J Microbiol Biotechnol; 2022 Apr; 32(4):493-503. PubMed ID: 35283423
[TBL] [Abstract] [Full Text] [Related]
17. Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium.
van der Ploeg P; Uittenboogaard A; Bosch SL; van Diest PJ; Wesseling-Rozendaal YJW; van de Stolpe A; Lambrechts S; Bekkers RLM; Piek JMJ
Gynecol Oncol; 2022 Apr; 165(1):114-120. PubMed ID: 35123772
[TBL] [Abstract] [Full Text] [Related]
18. Aulosirazoles B and C from the Cyanobacterium
Davis LJ; Maldonado AC; Khin M; Krunic A; Burdette JE; Orjala J
J Nat Prod; 2022 Mar; 85(3):540-546. PubMed ID: 35100504
[TBL] [Abstract] [Full Text] [Related]
19. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
[TBL] [Abstract] [Full Text] [Related]
20. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of foxo3.
Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
[TBL] [Abstract] [Full Text] [Related]
[Next]